Disposition of 56361 shares by Junyuan Wang of Nuvation Bio at 2.89 subject to Rule 16b-3
PROC Stock | USD 2.42 0.17 7.56% |
About 54% of Procaps Group's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Procaps Group SA suggests that some traders are interested. The current market sentiment, together with Procaps Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Procaps Group SA stock news signals to limit their universe of possible portfolio assets.
Procaps |
Filed transaction by Nuvation Bio Director, Officer: Ceo, Anheart Therapeutics Ltd.. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Procaps Group's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Procaps Group's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Procaps Group Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Procaps Group can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Procaps Group Fundamental Analysis
We analyze Procaps Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procaps Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procaps Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Procaps Group is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Procaps Group SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Procaps Group stock to make a market-neutral strategy. Peer analysis of Procaps Group could also be used in its relative valuation, which is a method of valuing Procaps Group by comparing valuation metrics with similar companies.
Peers
Procaps Group Related Equities
ANIP | ANI Pharmaceuticals | 1.95 | ||||
PBH | Prestige Brand | 1.14 | ||||
PAHC | Phibro Animal | 0.90 | ||||
COLL | Collegium Pharmaceutical | 1.50 | ||||
RGC | Regencell Bioscience | 5.80 |
Complementary Tools for Procaps Stock analysis
When running Procaps Group's price analysis, check to measure Procaps Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procaps Group is operating at the current time. Most of Procaps Group's value examination focuses on studying past and present price action to predict the probability of Procaps Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procaps Group's price. Additionally, you may evaluate how the addition of Procaps Group to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |